Job Openings at Biotech Pharmaceutical Co.,Ltd in Beijing China
Biotech Pharmaceutical Co., Ltd (hereinafter “BPL”), as the pioneer in China’s antibody industry, is devoted to development, research, production and commercialization of monoclonal antibody, therapeutic vaccine and other innovative biological medicine. Now BPL has already grown into the leading antibody company with mature technology and nation-wide sales network. BPL develops China’s first humanized mAb---TAI XIN SHENG (Nimotuzumab), which was launched in 2008. BPL never stops its pursuit in innovation and nowadays its pipeline consists of different biological medicine in different stages.
BPL is passionate about improving patients’ standard of life and believes that its action can make the world better. BPL is looking for
Chief Scientists/Senior Scientists/Head of R&D Institution, RESEARCH & DEVELOPMENT of antibody, fusion protein, particularly in the field of bio-specific antibody and immunotherapy
LOCATION: Beijing, China
QUALIFICATIONS:
· PhD degree in molecular biology, cell biology or other related science
· 5+ years experience in research and development,
· Experience in leading groups, project evaluation and management
Manager/Scientists/Senior Scientists, CLINICAL RESEARCH
LOCATION: Beijing, China
QUALIFICATIONS:
· PhD degree in medical science or other related sciences
· 5+ years experience in clinical investigation
· Experience in leading groups and project management
BPL CAN PROVIDE YOU:
· Competitive salary, bonus and other allowances
· Cutting-edge technology platform
· Formidable technology team (experts including by “1000 Talent Plan of High-level Foreign Experts” and “High-end Foreign Experts Program of Beijing”)
· Favorable working environment
IF YOU ARE SOMEONE WHO WOULD LIKE TO COME BACK TO CHINA TO MAKE CONTRIBUTION TO CHINA’S ANTIBODY INDURSTRY DEVELOPMENT, PLEASE CONTACT BPL BY THE FOLLOWING WAY:
TEL: 0086-13581651968; 0086-13520444882
EMAIL: miaocuifang@biotechplc.com
公司简介：
百泰生物药业有限公司主要从事单克隆抗体药物、治疗性疫苗等创新生物医药产品的研发和生产，是国内最早从事抗体研发的企业，也是国内抗体研发技术发展最为成熟的企业，先后承担了多项国家高新技术产业发展计划、国家高技术产业化示范工程等重大项目。公司成功开发了中国第一个人源化单克隆抗体-泰欣生尼妥珠单抗，已于2008年上市，2015年的销售额预计突破6亿元。
百泰生物积极开展国际化技术转化的同时，致力于培育自主创新能力，目前有多个新药正在研发当中。
招贤纳士：
我公司目前需要：
首席科学家/资深科学家/研究所所长
抗体药品研发、融合蛋白药品研究和开发方面的人才，特别是双特异性抗体研发和肿瘤免疫治疗技术和产品方面的研究和开发专家。
要求：
· 分子生物学或细胞生物学相关专业，博士以上学历
· 5年以上抗体类研发工作经验；
· 具有领导团队、项目开发、评估等方面的经验。
临床研究科学家/临床研究经理
药品临床研究方面的人才和专家
要求：
· 医学等相关专业，博士以上学历；
· 5年以上药品临床研究工作经验；
· 具有领导团队、项目管理等方面的经验。
我们为您提供：
· 有竞争力的薪酬福利待遇；
· 国内尖端的技术平台；
· 实力强大的技术团队（包含多名国家“千人计划”“海聚工程”入选专家）
· 良好的工作氛围
公司名称：百泰生物药业有限公司
联系电话：0086-13581651968；0086-13520444882
